Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.

Scientific director
Scientific production - Institute for Cancer Research
| Publications | Doctoral theses | |
| 2013 | so far | |
| 2012 | 192 | 18 |
| 2011 | 183 | 22 |
| 2010 | 198 | 11 |
| 2009 | 167 | 21 |
| 2008 | 144 | 11 |
The Institute is engaged in both basic and translational cancer research involving experimental research on model organisms from various evolutionary levels as well as human material from all types of cells and tissues. The co-localisation with a large cancer hospital fulfils the premises for advanced medical research across sciences, a necessity towards the goals of individualised diagnostics and treatment for cancer patients.
Jun 14, 2013
International approaches to personalized cancer medicine
Jun 5, 2013
Latest publications
Inst. for Cancer Research
Retrograde transport of protein toxins through the Golgi apparatus
Histochem Cell Biol (in press)
PubMed 23765164
HPV16 activates the AIM2 inflammasome in keratinocytes
Arch Dermatol Res (in press)
PubMed 23764897
Molecular profiling of tumor-specific TH1 cells activated in vivo
Oncoimmunology, 2 (5), e24383
PubMed 23762808
Selected publications
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
High-Purity Hydrogen via the Sorption-Enhanced Steam Methane Reforming Reaction over a Synthetic CaO-Based Sorbent and a Ni Catalyst
Environ Sci Technol, 47 (11), 6007-14
PubMed 23675760
A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells
FASEB J (in press)
PubMed 23671272
Influence of KIR gene copy number on natural killer cell education
Blood, 121 (23), 4703-7
PubMed 23637128




Go back
Print this page
E-mail this page
